Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

RETA GLP-3 research

6 articles to explore, with links to 7 original sources.

About RETA GLP-3

RETA GLP-3 is a research peptide listing associated with GLP-1, GIP, and glucagon receptor investigations.

Understand the science

  • How two retatrutide trials counted breathing interruptions during sleep

    Retatrutide is an investigational peptide that activates the GIP, GLP-1 and glucagon receptors. “RETA GLP-3” is a catalog label. Its number does not name a receptor target. A 2026 report examined retatrutide in adults with moderate to severe obstructive sleep apnea.

    3 sources (2025, 2026)

Explore study findings

  • What TRIUMPH-1 established about average weight change

    Retatrutide activates the GIP, GLP-1 and glucagon receptors, the three targets behind its description as a triple agonist. The “GLP-3” catalog wording refers to the entry, while the scientific names identify the receptors studied.

    2 sources (2025, 2026)

  • Why TRIUMPH-2 enrolled adults with type 2 diabetes

    Retatrutide is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. “GLP-3” is catalog wording for this triple agonist. The 2026 TRIUMPH-2 report asked what happened to body weight in participants who had both type 2 diabetes and excess body weight.

    2 sources (2026)

  • What retatrutide blood samples reveal about changing fuel use

    Retatrutide is an investigational peptide that activates the GIP, GLP-1 and glucagon receptors. The “GLP-3” label refers to the catalog entry.

    1 source (2026)

Check methods and identity

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.